ASH19: Serious vaso-occlusive crises eliminated in some sickle cell disease patients treated with bluebird bio’s LentiGlobin

0
5

ASH19: Serious vaso-occlusive crises eliminated in some sickle cell disease patients treated with bluebird bio’s LentiGlobin

LEAVE A REPLY

Please enter your comment!
Please enter your name here